Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Catalent announced it began Phase 2 clinical trials of MGB Biopharma.
read more
Wednesday, April 24, 2019
Sterling Pharma Solutions, has received a Queen’s Award for International Trade for Outstanding Short Term Growth in overseas sales.
read more
Yposkesi announces the appointment of Morad El Gueddari as production director, gene therapy operations.
read more
Paragon Bioservices announced it will be exploring the formation of a wide-ranging partnership in gene therapy manufacturing with Sarepta Therapeutics.
read more
Ology Bioservices announced the Department of Defense has awarded the company with two contracts valued at $135.4 million.
read more
Almac Group has announced additional expansion plans at its Athlone facility.
read more
MS Pharma has entered into an agreement to acquire 100% of the outstanding shares in Genepharm, a European pharmaceutical company.
read more
Wednesday, April 17, 2019
Greenfield Global has announced plans to establish a new EU manufacturing headquarters in Portlaoise, Ireland.
read more
Wednesday, April 17, 2019
Fibrocell announced a collaboration agreement with Castle Creek to develop and commercialize FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).
read more
Wednesday, April 17, 2019
Encube Ethicals has announced its new high potency manufacturing facility for topical formulations is now fully operational.
read more
Catalent and Paragon Bioservices announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion.
read more
Cambrex announced that it has completed the construction of a $24 million highly potent API (HPAPI) manufacturing facility at its site in Charles City, IA.
read more
Fujifilm Diosynth Biotechnologies has announced the reduction of cell line development timelines with its Apollo X™ Advanced Mammalian Expression System.
read more
Wednesday, April 10, 2019
ReNeuron has signed a license agreement with Shanghai Fosun Pharmaceutical for the development, manufacture and commercialization of ReNeuron's CTX and hRPC cell therapy programs in China.
read more
Ajinomoto Bio-Pharma Services announced GeneDesign has joined the global organization.
read more